Cipla acquires 4 nutrition brands from Wanbury
- IBEF
- February 10, 2020
Cipla, an Indian pharmaceutical firm, announced the acquisition of nutrition products portfolio from Wanbury Ltd.
In order to strengthen its portfolio is women's health segment, the company has acquired four brands namely CPink, CDense, Productiv and Folinine.
According to the Cipla regulatory filing, these nutraceutical products will be sold under the four umbrella brands, covering various health needs for conditions arising due to nutritional deficiencies or insufficiencies.
This consist of supplements such as multivitamins, multimineral and antioxidants for adolescent girls, pregnant and lactating women, women going through menopause and for male and female reproductive health, it added.
It further added that through this newly acquired portfolio, the company shall be catering to a wide range of patient's needs including nutritional deficiencies, bone health and sexual health.
Previously, these above molecules were commercialized by Wanbury and had a market size of Rs 3,100 crore (US$ 443.55 million) in India with sales value of Rs 59.6 crore (US$ 8.53 million).
Disclaimer: This information has been collected through secondary research and IBEF is not responsible for any errors in the same.
Partners
